Received Oct 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
Shingrix Late second dose; This non-serious case was reported by a pharmacist via sales rep and described the occurrence of incomplete course of vaccination in a 75-year-old female patient who did not receive Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (in 2020 5 years ago). On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, the patient had incomplete course of vaccination (Verbatim: Shingrix Late second dose). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 30-SEP-2025 The patient received 1st dose of Shingrix. The reporter asked regarding restart the series or just receive the 2nd dose of Shingrix and be done complete series. Batch number "ASKU": The batch number was not provided upon follow up with the reporter.